WO1988004671A1 - Biostatic and biocidal compositions - Google Patents

Biostatic and biocidal compositions Download PDF

Info

Publication number
WO1988004671A1
WO1988004671A1 PCT/AU1987/000435 AU8700435W WO8804671A1 WO 1988004671 A1 WO1988004671 A1 WO 1988004671A1 AU 8700435 W AU8700435 W AU 8700435W WO 8804671 A1 WO8804671 A1 WO 8804671A1
Authority
WO
WIPO (PCT)
Prior art keywords
biostatic
biocidal
acrolein
polymeric
substrate
Prior art date
Application number
PCT/AU1987/000435
Other languages
French (fr)
Inventor
Graham John Hamilton Melrose
Concetta Maria Kleppe
Jeffrey Wayne Langley
Jeffrey Mark Stewart
Jacobus Van Dyk
Original Assignee
Biopolymers Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopolymers Limited filed Critical Biopolymers Limited
Priority to KR1019880701031A priority Critical patent/KR950008720B1/en
Priority to DE3789150T priority patent/DE3789150T2/en
Priority to IN992/CAL/87A priority patent/IN166555B/en
Publication of WO1988004671A1 publication Critical patent/WO1988004671A1/en
Priority to AT88900672T priority patent/ATE101860T1/en
Priority to NO883639A priority patent/NO173737C/en
Priority to DK198804697A priority patent/DK174224B1/en
Priority to SG81394A priority patent/SG81394G/en
Priority to HK103394A priority patent/HK103394A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F16/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical
    • C08F16/34Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical by an aldehydo radical
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/02Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals

Definitions

  • BIOSTATIC AND BIOCIDAL COMPOSITIONS The present invention relates to new polymeric biocidal or biostatic compounds and to the treatment of substrates or substrate materials therewith and relates particularly but not exclusively to polymeric acrolein biocidal or biostatic compounds and to substrates or substrate materials treated therewith.
  • a biocidal substance kills micro ⁇ organisms and a biostatic substance inhibits the growth of microorganisms; microorganisms including for example, bacteria, fungi and viruses.
  • aldehydes such as glutaraldehyde and formaldehyde are biocidal or biostatic and that substrates or substrate materials may be treated with such substances or compositions to render them at least temporarily biocidal or biostatic.
  • the disadvantages of the use of such substances or such compositions is that the aldehydes have penetrating, obnoxious odours and are volatile thus rendering them unsuitable for long term biocidal or biostatic treatment of substrates or substrate materials.
  • untreated substrates or substrate materials may be subject to deterioration or production of odours or formation of obnoxious or slippery slime or mildew or give rise to inflammation or transfer of disease.
  • odours or formation of obnoxious or slippery slime or mildew or give rise to inflammation or transfer of disease.
  • biostatic or biocidal compounds or compositions are relatively low molecular weight and therefore pass relatively freely through biological membranes such as the skin or the intestinal wall and in both cases, into the blood stream of humans or animals where they may give rise to antigenic, allergenic or toxic effects; similar destructive or toxic results may arise from for example, passage through the roots or outer membranes of fruits or vegetables.
  • biological membranes such as the skin or the intestinal wall and in both cases, into the blood stream of humans or animals where they may give rise to antigenic, allergenic or toxic effects; similar destructive or toxic results may arise from for example, passage through the roots or outer membranes of fruits or vegetables.
  • CHO may be utilized as biocidal or biostatic compounds and for the treatment of substrates or substrate materials to render them biocidal or biostatic.
  • polymeric compounds having this repeating unit do not exist at equilibrium, entirely in these illustrated open chain forms in which the aldehyde groups are entirely un-associated.
  • polymers or copolymers- of acrolein or of an aldehyde- derivative of acrolein may be utilised as biostatic or biocidal compounds and for the treatment of substrates or substrate materials to render them biostatic or biocidal.
  • the invention lies in the. recognition of the similarities in structure between glutaraldehyde, which is a known bacteriostat and bacteriocide, and polymers or copolymers of. acrolein or of an aldehyde-derivative of acrolein.
  • glutaraldehyde which is a known bacteriostat and bacteriocide
  • polymers or copolymers of. acrolein or of an aldehyde-derivative of acrolein In the case of polyacrolein, for example, at equililbrium the structure takes on a number of different forms; it is generally agreed (E. Bergman, W.T. Tsatsos and R.F. Fischer, J. Polymer Sci: Part A, 1965, 3485; R.C. Schulz, Vinyl Polym. , 1967, 1, 403; L. Hunter and J. . Forbes, J. Polymer Sci: Part A, 1965, 3, 3471 that sub-units of polyacro
  • Figure 1 in which either the form (d) or the tetrahydropyran ring- form (b) or the fused tetrahydropyran ring-form (c) predominate.
  • 13 C-NMR analysis of polyacrolein produced by a free radical inducing agent (free radical catalyst) showed negligible aldehyde carbon, which is consistent with the above structures; the spectrum also showed a number of aliphatic CH's and CH 2 's and a number of O-CH-O's which are all expected from the above variety of structures.
  • Glutaraldehyde is proposed to exist in the following forms (A.D. Russell and D. Hopwood, "Progress in Medicinal Chemistry", Vol. 13, Eds. G.P. Ellis and G.B. West, North Holland Publishing Company, 1976):
  • an added advantage of these polymers or copolymers of acrolein or of an aldehyde- derivative of acrolein is that their hydrophilicity/hydro- phobicity or water solubility/oil or lipid solubility may be widely adjusted by the inclusion or exclusion, respectively, of hydrophilic comonomers, for example, acrylic acid, vinyl pyrrolidone, vinyl or acrylic monomers containing oxygen-containing groups for example, hydroxyl groups, or ether groups or carboxyl groups, or other similar hydrophilic monomers which will now be apparent to those skilled in the art.
  • hydrophilic comonomers for example, acrylic acid, vinyl pyrrolidone, vinyl or acrylic monomers containing oxygen-containing groups for example, hydroxyl groups, or ether groups or carboxyl groups
  • the homopolymers of acrolein are water-insoluble and are thus suited to applications where their elution by aqueous media are not desirable as in sprays for agricultural or veterinary purposes or in applications where the utility of the polyacrolein is sought in oil phases such as some cosmetic/toiletry preparations or foods or engine oils; alternatively, the inclusion of a high percentage of hydrophilic comonomer for example, acrylic acid renders the resulting copolymer suited to use in hydrophilic media which is more usual in cosmetics, toiletries, pharmaceuticals or food substances.
  • Water- dispersable or water-soluble copolymers of acrolein for example ' , the 90:10 acrylic acid: acrolein copolymer is especially suited as a sterilent, sanitiser, antimicrobial or preservative in cosmetics, toiletries, pharmaceuticals or food substances.
  • a particular application which we record is that we project copolymers of acrolein or of a carbonyl- derivative of acrolein may be dissolved in an aqueous solution or in a gel-like medium formed through, for example, the presence of carboxy ethylcellulose and then the resulting solution or gel used as a rectal suppository to combat the transmission of AIDS virus amongst homosexuals.
  • solution or gel could be enclosed in a small tube (as toothpaste is conventionally dispensed) - the cap of the tube incorporating a syringe-needle which is made available to drug addicts who are in danger of transmitting AIDS through unclean injection-techniques; of course, the storing of the syringe-needle in the solution or gel would have a biostatic or biocidal effect against the aids micro ⁇ organism.
  • a further advantage of the said polymers or copolymers of acrolein or of a derivative of acrolein is that their biostatic or biocidal activities appear to be less pH-dependent than glutaraldehyde (see S.D. Rubbs et al. J. Appl. Bact., 1967, 30(1), 78).
  • An advantage of using an aldehyde-derivative of acrolein is absence or greatly reduced acrid smell, compared with acrolein, during the polymerization. Of course, however, all final polymers and even those prepared from acrolein are essentially odour-free.
  • Substrates which can be treated with the compounds of the invention include cellulose, modified cellulose, regenerated cellulose, rayon, polymers of plastic materials such as vinyl polymers, acrylic polymers and polyesters, rubbers and various materials such as ceramics, glass, silica, concrete, masonry, minerals and earths.
  • substrate materials which may be made by such substrates are:
  • Airconditioner filters air-line wipes, aprons, bags for laundry, bandages or adhesive bandages, bathroom tiles or grout, bricks, car or other carpets, catheters and related hospital instruments made from plastic or glass, clothing including underwear, cloth wraps for food, concrete, cotton- balls or cotton tips (buds), diapers, disposable towels, drapes (domestic, commercial, industrial or hospital), _ ?
  • the rendering of the substrate biocidal or biostatic either prevents microbiological degradation of the substrate, prevents the production of odours which may result from degradation of the substrate or from the degrad ⁇ ation of chemical compounds contained in or within the substrate. This rendering also prevents the substrate from being a vector of inflammation or disease. Further, mould, lichen or other similar formation on the substrate may be prevented.
  • the biostatic or biocidal agent of the present invention may be associated with materials from which substrates are made, so as to be incorporated into the final product or alternatively, the finally fabricated substrate may be suitably treated to associate it with the biocidal or biostatic agent.
  • the present invention therefore provides a polymeric biocidal or biostatic compound having the polymeric repeating unit
  • CHO CHO or this repeating unit in hydrated, hemi-acetal or acetal forms described earlier such biostatic or biocidal compound having the repeating unit(s) being derived from a polymer or copolymer of acrolein or of an aldehyde-derivative of acrolein.
  • the invention also provides a composition of matter comprising a polymeric biocidal or biostatic compound having the polymeric repeating unit
  • biostatic or biocidal compound having the repeating units(s) being derived from a polymer or copolymer of acrolein or of an aldehyde-derivative of acrolein bound to a substrate or substrate material.
  • the invention also provides a process for preparing a polymeric biocidal or biostatic compound having the polymeric repeating unit
  • CHO CHO or this repeating unit in hydrated, hemi-acetal or acetal forms described earlier such biostatic or biocidal compound having the repeating unit(s) being derived from a polymer or copolymer of acrolein. or of an aldehyde-derivative of acrolein such polymerisation taking place in the presence of a polymerisation— inducing agent; the agent is either a free-radical initiator, or an ionic initiator.
  • the invention also provides a method of producing a composition of matter which comprises polymerizing acrolein or a derivative thereof in the presence of or with a _
  • substrate or substrate material preferably in the presence of a polymerization inducing agent.
  • the polymerization inducing agent is preferably selected from gamma radiation, such as is produced by a radioactive cobalt source.
  • the 13 C-NMR spectrum shows some residual acrolein with the aldehyde carbon at 5196.72 and the vinylic CH 2 and CH at 5139.78 and 5139.36, respectively; apart from the 5196.72 (CH) resonance absorption, there was no other attributed to -CHO.
  • the spectrum is consistent with polymeric acrolein consisting of fused tetrahydropyran rings and some free dihydroxy methyl groups. The rings exist in either the boat or chair configurations giving rise to more chemical shifts than may be expected.
  • a similar polymerization of acrolein was also carried out: 25.02g methanol was placed in a reaction vessel fitted with a thermometer, reflux condenser and nitrogen inlet tube. 0.528g of benzoyl peroxide was added and 9.65g of distilled acrolein was added. The system was purged with nitrogen and heated in an oil bath at 60 degrees centigrade with stirring, for 24 hours; when a solids determination indicated 20% conversion; total conversion was 40% after a further 48 hours heating.
  • the polyacrolein was found to have a retention time which was shorter than that of polyethyleneglycol 10,000 on a Porasil GPC 60 Angstrom column using a Waters Associated Model ALC/GPC 204 liquid chro atograph fitted with a differential refractometer R401.
  • the polyacrolein was found to have a retention time which was shorter than that of polyethylene glycol 10,000.
  • acrolein diethyl acetal 2.8g was placed in a 100 nil round bottom flask and the contents purged with nitrogen. A solution of.0.216g potassium persulphate in 7.5g water was added with stirring, under nitrogen. The flask was placed in an oil bath at 60-70 degrees centigrade and stirred for ca. 20 hours. A yellow solid was recovered and dried at 50 degrees centigrade; weight 0.915g.
  • a 50:50 mixture of monomers was treated as follows: 2.35g distilled acrolein, 2.88g distilled acrylic acid and 14.5g methanol were placed in a 50ml round bottom flask and flushed with nitrogen. 0.2625g benzoyl peroxide was added and after heating at 60-70 degrees centigrade for 48 hours the conversion was 70%. The polymer swelled in methanol but was insoluble in water.
  • Example 12 Similar preparations were achieved with different ratios of the monomers acrolein: acrylic acid namely, 30:70 (Example 9), ' 10:90 (Example 10), 2.5:97.5 (Example 11).
  • the . products from Examples 10 and 11 were soluble in water and retained by dialysis tubing of exclusion 2,000mwt.
  • Example 12
  • Filter papers were dried in an oven at 70 degrees 0 centigrade for 30 minutes and weighing indicated the grafting of polymer 0.8%-12.6%. (These yields were recorded after washing with methanol).
  • Example 20 5 A small cellulosic paper disk which is normally used for filtration i.e. a filter paper, about 2 cms. in diameter was immersed in a 10% solution of acrolein in water (10 ml), contained in a tube. The tube and its contents were flushed with nitrogen, sealed, and then gamma-radiated for one hour from a cobalt source (approximately 0.7 Mrad/hour). The disk was then removed and washed with water.
  • a cobalt source approximately 0.7 Mrad/hour
  • Dilutions were prepared in normal saline. lOul of each bacterial solution was applied to 1 square centimetre of test filter paper. Filter papers were maintained in a moist atmosphere at room temperature for 2 hours. Filter papers were then transferred to 5ml heart brain infusion and shaken at 37 degrees centigrade for 30 minutes. lOul was removed for sterility testing and the flasks incubated at 37 degrees centigrade for 18 hours. The flasks were inspected for growth and the growth was checked on blood agar.
  • Whatman No. 4 filterpaper was impregnated with a solution of polyacrolein in methanol which had been polymerised by means of gamma-radiation) and dried in an oven at 70 degrees centigrade for 1 hour. The amount of impregnated polymeric antimicrobial was 9%. The impregnated filter paper was tested for antimicrobial activity and the results were recorded by comparing with a control filter ⁇ paper.
  • Candida ATCC Dilutions were prepared in normal saline. lOul of each bacterial dilution was applied to 1 square centimetre of test filter paper. The filter papers were maintained in a moist atmosphere at room temperature for 2 hours. Then the filter papers were transferred to 5ml heart brain infusion and shaken at 37 degrees centigrade for 30 minutes. 1.0ul was removed for sterility testing and the flasks incubated at 37 degrees centigrade for 18 hours. The flasks were inspected for growth and the growth was checked on blood agar.
  • Whatman No. 4 filterpaper was impregnated with a solution of polyacrolein.
  • methanol which has been prepared by polymerising 19.3g distilled acrolein in 58 g methanol in the presence of 1.05g benzoylperoxide in a nitrogen atmosphere for 3 days at 70 degrees centigrade.
  • the amount of impregnated polymeric antimicrobial was 8%.
  • the impregnated filterpaper was tested for antimicrobial activity and the results were recorded by comparing with a control filterpaper.
  • cotton wool was impregnated with a solution of polyacrolein in methanol which had been prepared by polymerizing 19.3g distilled acrolein in 58g methanol in the presence of 1.05 g benzoylperoxide in a nitrogen atmosphere for 3 days at 70 degrees centigrade.
  • the amount of impregnated, polymeric antimicrobial was 5% and 3.5% respectively.
  • the impregnated cottonwools were tested for antimicrobial activity and the results were recorded by comparing with control cottonwool.
  • laboratory scale examples may be extended to industrial scale processes, for example, in which the substrate cellulose, prior to incorporation in, for example, tampons, diapers or medical cellulosic products is treated with acrolein vapour or acrolein solution and is then gamma-irradiated. Further, the process may be extended to the continuous (as well as batch) industrial processes in which cotton, cellulosic fibre or other fibres ⁇ are treated with acrolein vapours or solution prior to weaving or making into a non-woven fabric. Still further, the laboratory scale example may be extended to treating sheets, fabrics or cloths prior to making into clothes, drapes and other similar finished products. Still further, the example may be extended to treating the starting-materials or their final products such as ceramics, masonry, bricks, concrete, glass or plastics materials either prior to or after making these into their final fabricated forms.
  • Cotton (3.876g) with a 3% content of polyacrolein was agitated in saline (75ml) for 24 hours.
  • the saline extract was analysed by GLC (10% carbowax 20M and on FID detector) which showed that the cotton contained less than 20ppm (the limit of detection).
  • the saline extract (50ml) was added to a solution of 2,4-dinitrophenylhydrazine (O.lOOg) in 2N hydrochloric acid (25ml). The resultant solution was extracted with chloroform (3 x 5ml). The combined organic fractions were then washed with 2N hydrochloric acid (2 x 5ml), water (2 x 5ml) and dried (sodium sulphate). The chloroform was evaporated to dryness and the residue dissolved in aceto- nitrile (1ml). Analysis of the acetonitrile by HP C (C18 reverse phase, 70% aqueous mmethanol, UV detector at 245nm) showed that the cotton contained 2.4ppm of acrolein.
  • HP C C18 reverse phase, 70% aqueous mmethanol, UV detector at 245nm
  • substrates which were found to be micro- biologically active retained their activities after more than 6 months' standing at room temperature.
  • kills were achieved in the range 10 2 -10 5 /ml of Aureobasidium pullurans (associated with black-slime on bathroom tiles and groutings) and pycnoporus coccineus (associated with rotting in timbers) .
  • PR8 a 10 4 /ml suspension of the viral particles was applied to cottonwool treated with the antimocrobial polymer, followed by centrifugation. 0.1 ml aliquots of the centrifugate were introduced into cultures of human embryonic fibroblasts or HeLa cells and the cytopathic effect noted.
  • Staphylococcus Pseudomonas
  • Candida referred to herein are more specificically identified as: • Staphlycoccus aureus NCTC 6571

Abstract

Polymeric compounds having a polyacrolein sub unit in aldehyde, hydrated, hemi acetal or acetal form have biocidal or biostatic properties. The polymeric compound may be used to treat, or be included in, a wide range of products.

Description

_ _ _
BIOSTATIC AND BIOCIDAL COMPOSITIONS The present invention relates to new polymeric biocidal or biostatic compounds and to the treatment of substrates or substrate materials therewith and relates particularly but not exclusively to polymeric acrolein biocidal or biostatic compounds and to substrates or substrate materials treated therewith.
As is well known a biocidal substance kills micro¬ organisms and a biostatic substance inhibits the growth of microorganisms; microorganisms including for example, bacteria, fungi and viruses. It is also known that aldehydes such as glutaraldehyde and formaldehyde are biocidal or biostatic and that substrates or substrate materials may be treated with such substances or compositions to render them at least temporarily biocidal or biostatic. The disadvantages of the use of such substances or such compositions is that the aldehydes have penetrating, obnoxious odours and are volatile thus rendering them unsuitable for long term biocidal or biostatic treatment of substrates or substrate materials.
As a .result of microbial action, untreated substrates or substrate materials may be subject to deterioration or production of odours or formation of obnoxious or slippery slime or mildew or give rise to inflammation or transfer of disease. Thus, it is desirable that such substrates or substrate materials can be treated to render them biocidal or biostatic.
Another disadvantage of ,-such conventional biostatic or biocidal compounds or compositions is that they are relatively low molecular weight and therefore pass relatively freely through biological membranes such as the skin or the intestinal wall and in both cases, into the blood stream of humans or animals where they may give rise to antigenic, allergenic or toxic effects; similar destructive or toxic results may arise from for example, passage through the roots or outer membranes of fruits or vegetables. Thus, there is a need for biostatic or biocidal compounds or compositions which do not readily pass through biological membranes.
It has now been discovered that polymeric compounds having, illustratively, the repeating unit
- CH2 - CH - CH2 - CH - CHO CHO may be utilized as biocidal or biostatic compounds and for the treatment of substrates or substrate materials to render them biocidal or biostatic. However, it is stressed that such polymeric compounds having this repeating unit do not exist at equilibrium, entirely in these illustrated open chain forms in which the aldehyde groups are entirely un-associated. Specifically, we have discovered that polymers or copolymers- of acrolein or of an aldehyde- derivative of acrolein may be utilised as biostatic or biocidal compounds and for the treatment of substrates or substrate materials to render them biostatic or biocidal.
The invention lies in the. recognition of the similarities in structure between glutaraldehyde, which is a known bacteriostat and bacteriocide, and polymers or copolymers of. acrolein or of an aldehyde-derivative of acrolein. In the case of polyacrolein, for example, at equililbrium the structure takes on a number of different forms; it is generally agreed (E. Bergman, W.T. Tsatsos and R.F. Fischer, J. Polymer Sci: Part A, 1965, 3485; R.C. Schulz, Vinyl Polym. , 1967, 1, 403; L. Hunter and J. . Forbes, J. Polymer Sci: Part A, 1965, 3, 3471 that sub-units of polyacrolein produced by a free radical inducing agent have the structures below ((a); R=H) :
Figure imgf000004_0001
(a) (b)
Figure imgf000005_0001
x = in
Figure imgf000005_0002
Figure 1 in which either the form (d) or the tetrahydropyran ring- form (b) or the fused tetrahydropyran ring-form (c) predominate. 13C-NMR analysis of polyacrolein produced by a free radical inducing agent (free radical catalyst)showed negligible aldehyde carbon, which is consistent with the above structures; the spectrum also showed a number of aliphatic CH's and CH2's and a number of O-CH-O's which are all expected from the above variety of structures.
In keeping with proposals of R.C. Schulz, Vinyl Polym. , 1967, 1, 403, the 3C-NMR spectrum of polyacrolein produced by an ionic catalyst is consistent with the above structures for the polymer and additionally, the presence of structures (a) and (b) of Figure 2.
Figure imgf000005_0003
(a)
Figure imgf000005_0004
(b)
Figure 2 The 1 3C-NMR spectrum, of a copolymer of acrolein diethylacetal : acrylic acid was consistant with the polymer having repeating units illustrated by Figure 1 (a); R = CH3 CH2.
Glutaraldehyde is proposed to exist in the following forms (A.D. Russell and D. Hopwood, "Progress in Medicinal Chemistry", Vol. 13, Eds. G.P. Ellis and G.B. West, North Holland Publishing Company, 1976):
Figure imgf000006_0001
(a) (b)
Figure imgf000006_0002
(c) (d)
Figure imgf000006_0003
(e)
Figure imgf000006_0004
(f) x,y,z = integers of 1 or more
Figure 3 The '13C-NMR analysis of glutaraldehyde showed that very ' little of the glutaraldehyde (less than 5%) existed in the free aldehyde form (a). There were many aliphatic CH2 resonances evident in the spectrum with the major peaks numbering eleven. There were also many O-CH-O resonances with nine major peaks. This supports the existence of the above cyclic structures as the linear forms of glutar¬ aldehyde would not give rise to so many different resonances. According to our invention, an added advantage of these polymers or copolymers of acrolein or of an aldehyde- derivative of acrolein is that their hydrophilicity/hydro- phobicity or water solubility/oil or lipid solubility may be widely adjusted by the inclusion or exclusion, respectively, of hydrophilic comonomers, for example, acrylic acid, vinyl pyrrolidone, vinyl or acrylic monomers containing oxygen-containing groups for example, hydroxyl groups, or ether groups or carboxyl groups, or other similar hydrophilic monomers which will now be apparent to those skilled in the art. Normally, the homopolymers of acrolein are water-insoluble and are thus suited to applications where their elution by aqueous media are not desirable as in sprays for agricultural or veterinary purposes or in applications where the utility of the polyacrolein is sought in oil phases such as some cosmetic/toiletry preparations or foods or engine oils; alternatively, the inclusion of a high percentage of hydrophilic comonomer for example, acrylic acid renders the resulting copolymer suited to use in hydrophilic media which is more usual in cosmetics, toiletries, pharmaceuticals or food substances. Water- dispersable or water-soluble copolymers of acrolein, for example', the 90:10 acrylic acid: acrolein copolymer is especially suited as a sterilent, sanitiser, antimicrobial or preservative in cosmetics, toiletries, pharmaceuticals or food substances. A particular application which we record is that we project copolymers of acrolein or of a carbonyl- derivative of acrolein may be dissolved in an aqueous solution or in a gel-like medium formed through, for example, the presence of carboxy ethylcellulose and then the resulting solution or gel used as a rectal suppository to combat the transmission of AIDS virus amongst homosexuals. Also the solution or gel could be enclosed in a small tube (as toothpaste is conventionally dispensed) - the cap of the tube incorporating a syringe-needle which is made available to drug addicts who are in danger of transmitting AIDS through unclean injection-techniques; of course, the storing of the syringe-needle in the solution or gel would have a biostatic or biocidal effect against the aids micro¬ organism.
A further advantage of the said polymers or copolymers of acrolein or of a derivative of acrolein is that their biostatic or biocidal activities appear to be less pH-dependent than glutaraldehyde (see S.D. Rubbs et al. J. Appl. Bact., 1967, 30(1), 78).
An advantage of using an aldehyde-derivative of acrolein is absence or greatly reduced acrid smell, compared with acrolein, during the polymerization. Of course, however, all final polymers and even those prepared from acrolein are essentially odour-free.
Substrates which can be treated with the compounds of the invention include cellulose, modified cellulose, regenerated cellulose, rayon, polymers of plastic materials such as vinyl polymers, acrylic polymers and polyesters, rubbers and various materials such as ceramics, glass, silica, concrete, masonry, minerals and earths.
Examples of substrate materials which may be made by such substrates are:
Airconditioner filters, air-line wipes, aprons, bags for laundry, bandages or adhesive bandages, bathroom tiles or grout, bricks, car or other carpets, catheters and related hospital instruments made from plastic or glass, clothing including underwear, cloth wraps for food, concrete, cotton- balls or cotton tips (buds), diapers, disposable towels, drapes (domestic, commercial, industrial or hospital), _ ? _ disposable cardboard or plastic food boxes, face masks (hospital or industrial) bed covers, inners of shoes, ironing board covers, jumpers or cardigans, nursing pads, paint for ships' hulls or underwater pylons, paper plates and cups, water reservoirs or swimming pools or water- treatment chemicals, rubbish bins made from cardboard or plastic, sanitary napkins or feminine hygiene tampons, sheeting for babies' or incontinent persons' beds, shelving paper, shower curtains, socks, sterile gloves, sterile overalls, teatowels, telephones - diaphragms for mouth pieces, tentsr tissues, handkerchiefs, toilet paper, toothbrush nylons, towels, wall paper, window awnings or other like structures made from canvas plastic etc., wipes, mops, sponges, wood or wood-impregnants. It has now also been discovered that polymerization of acrolein or an aldehyde-derivative of acrolein, with or without other comonomer in the presence of a substrate or substrate material causes the polymer to chemically bond to the substrate such as through graft polymerization. This has the advantage that the biocidal or biostatic agent is not readily removed from the substrate. Thus, the effect of the biocidal or biostatic agent may be longer-lasting than in cases where there is no chemical bond.
The rendering of the substrate biocidal or biostatic either prevents microbiological degradation of the substrate, prevents the production of odours which may result from degradation of the substrate or from the degrad¬ ation of chemical compounds contained in or within the substrate. This rendering also prevents the substrate from being a vector of inflammation or disease. Further, mould, lichen or other similar formation on the substrate may be prevented. The biostatic or biocidal agent of the present invention may be associated with materials from which substrates are made, so as to be incorporated into the final product or alternatively, the finally fabricated substrate may be suitably treated to associate it with the biocidal or biostatic agent. _ Q _
The present invention therefore provides a polymeric biocidal or biostatic compound having the polymeric repeating unit
- CH2 - CH - CH2 - CH -
CHO CHO or this repeating unit in hydrated, hemi-acetal or acetal forms described earlier (Figures 1 and 2), such biostatic or biocidal compound having the repeating unit(s) being derived from a polymer or copolymer of acrolein or of an aldehyde-derivative of acrolein. The invention also provides a composition of matter comprising a polymeric biocidal or biostatic compound having the polymeric repeating unit
Figure imgf000010_0001
or this repeating unit in hydrated, hemi-acetal or acetal forms described earlier (Figures 1 and 2), such biostatic or biocidal compound having the repeating units(s) being derived from a polymer or copolymer of acrolein or of an aldehyde-derivative of acrolein bound to a substrate or substrate material. The invention also provides a process for preparing a polymeric biocidal or biostatic compound having the polymeric repeating unit
- CH2 - CH - CH2 - CH -
CHO CHO or this repeating unit in hydrated, hemi-acetal or acetal forms described earlier (Figures,-1 and 2), such biostatic or biocidal compound having the repeating unit(s) being derived from a polymer or copolymer of acrolein. or of an aldehyde-derivative of acrolein such polymerisation taking place in the presence of a polymerisation— inducing agent; the agent is either a free-radical initiator, or an ionic initiator.
The invention also provides a method of producing a composition of matter which comprises polymerizing acrolein or a derivative thereof in the presence of or with a _
- 9 " substrate or substrate material preferably in the presence of a polymerization inducing agent. The polymerization inducing agent is preferably selected from gamma radiation, such as is produced by a radioactive cobalt source. The invention will now be illustrated by the following non- limitative examples.
Example 1
Preparations and Structures of Polyacrolein (a) Using a free radical inducing agent (free radical catalyst): 9.64g distilled acrolein and 25g methanol were placed in a 100ml round bottom flask and purged with nitrogen. 0.525g benzoyl peroxide was added and the solution stirred under nitrogen at 60 degrees centigrade. The reaction was allowed to continue for a total of ca. 88 hours. After this time the reaction solution had become strongly yellow in colour and had a solids content of 30.5%.
13C-NMR (300MHZ) δ( relative to d4-methanol at 49.00): 33.27 (CH); 33.53 (CH); 33.79 (CH) ; 33.87 (CH2 ) ; 37.03 (CH); 37.29 (CH); 37.54 (CH); 37.64 (CH2 ) ; 97.15 (CH); 103.37, (CH); 104.34 (CH); 139.36 (CH); 139.78(CH2); 196.72 (CH). The 13C-NMR spectrum shows some residual acrolein with the aldehyde carbon at 5196.72 and the vinylic CH2 and CH at 5139.78 and 5139.36, respectively; apart from the 5196.72 (CH) resonance absorption, there was no other attributed to -CHO. The spectrum is consistent with polymeric acrolein consisting of fused tetrahydropyran rings and some free dihydroxy methyl groups. The rings exist in either the boat or chair configurations giving rise to more chemical shifts than may be expected.
A similar polymerization of acrolein was also carried out: 25.02g methanol was placed in a reaction vessel fitted with a thermometer, reflux condenser and nitrogen inlet tube. 0.528g of benzoyl peroxide was added and 9.65g of distilled acrolein was added. The system was purged with nitrogen and heated in an oil bath at 60 degrees centigrade with stirring, for 24 hours; when a solids determination indicated 20% conversion; total conversion was 40% after a further 48 hours heating.
Typically, as an indication of .molecular weight, the polyacrolein was found to have a retention time which was shorter than that of polyethyleneglycol 10,000 on a Porasil GPC 60 Angstrom column using a Waters Associated Model ALC/GPC 204 liquid chro atograph fitted with a differential refractometer R401.
(b) Using an ionic catalyst: 1.6g distilled acrolein was made up to 20ml with deionised water in a 200ml beaker and then, ca. 0.5ml of 0.2M sodium hydroxide added with stirring to pH ca. 10-11. The solution became cloudy and a white precipitate began to form. The contents were stirred for a further 2 hours and then filtered. The precipitate was washed thoroughly with deionised water until the filtrate was neutral. The product was dried under vacuum and was a white-pale yellow, fine powder; it readily dissolved in methanol — and conveniently and importantly, could be evaporated down to dryness and then again, dissolved in methanol or other solvents. In a similar determination. to the above, the polyacrolein was found to have a retention time which was shorter than that of polyethylene glycol 10,000. ^13C-NMR (300MHz) 5(relative to d4-methanol at 49.00): 19-31 (CH2); 35.95 (CH2); 37-42 (CH); 62-73 (CH2) 73-81 (CH) ; 92-95 (CH); 96-103 (CH) ; 114-120 (CH2); 134-141 (CH); 196.0 (CH) .
Example 2
Preparation of 90:10 Acrylic Acid: Acrolein Copolymer 6.489g distilled acrylic acid, 0.56g distilled acrolein and 15g methanol were placed in a 50ml round bottom- flask and purged with nitrogen. 0.33g benzoyl peroxide was added and the solution stirred under nitrogen at 60-65 degrees centigrade. The reaction was continued for ca. 66 hours. After this time the contents of the flask had become very viscous, having a solids content of 57.7% (indicating 100% conversion) . A sample of the viscous material was placed on a petri dish and dried on a hot plate to remove solvent. Drying was completed in an oven at 80 degrees centigrade and a transparent, slightly yellow coloured polymer was obtained. The copolymer is completely soluble in warm water (ca. 50 degrees centigrade) and once dissolved remains so, even on cooling the solution.
In order to ensure that the solids obtained were polymeric, a simple dialysis experiment was performed: lOg of an aqueous solution containing 0.65% solids was placed in a dialysis tube. This was irrigated with water continuously for ca. 66 hours. The solution in the dialysis tube was then recovered and the solids content determined at 0.68%. Since the solids were completely retained and the lower limit for solids penetration through the dialysis tube is 2000 mwt, we conclude that the solids are polymeric
Example 3
2.8g of acrolein diethyl acetal was placed in a 100 nil round bottom flask and the contents purged with nitrogen. A solution of.0.216g potassium persulphate in 7.5g water was added with stirring, under nitrogen. The flask was placed in an oil bath at 60-70 degrees centigrade and stirred for ca. 20 hours. A yellow solid was recovered and dried at 50 degrees centigrade; weight 0.915g.
Example 4
4g distilled acrylic ac^d, 4.81g acrolein diethyl acetal and 15g methanol were placed in a 50ml round bottom flask and purged with nitrogen. Then 0.3g benzoyl peroxide was added and stirring continued under nitrogen at 60-65 degrees centigrade for 70 hours (solids determination indicated a 50% conversion). 13C-NMR (300MHz) δ(relative to d4-methanol at 49.00): 15.58 (CH3 ) ; 18.31 (CH. ) ; 35.52 (CH2); 36.24 (CH2 ) ; 37.07 (CH. ) ; 42.36 (CH) ; 42.85 (CH) ; 58.32 (CH2); 130.00 (CH) ; 131.57 (CH2 ) ; 178.51 (CH) . Example 5
3.8g of acrolein diethyl acetal, 3.3g vinyl pyrrolidone and lOg methanol were placed in 50ml round bottom flask and thoroughly purged with nitrogen. 0.71g azobisisobutyronitrile was added and the flask heated in an oil bath at 60-65 degrees centigrade, with stirring under nitrogen for 72 hours when the conversion was 44%. The copolymer was found to be soluble in methanol. Example 6
In a similar technique to the above, 3.9g acrolein diethyl acetal, 1.16g acrylic acid, 7.5ml water and 0.216g potassium persulphate were heated under nitrogen, with stirring in an oil bath at 60-70 degrees centigrade for ca. 24 hours when a white waxy material was recovered; it was insoluble in water, but swelled in methanol, acetone, tetra- hydrofaran or methyl ethyl ketone.
Example 7
A similar result was achieved through heating and stirring in the usual way to the above: 14.5g methanol, 3.62g distilled acrolein, 1.21g distilled acrylic acid and 0.265g benzoyl peroxide. Afte.r 40 hours the conversion was 40%.
Examples 8-11
A 50:50 mixture of monomers was treated as follows: 2.35g distilled acrolein, 2.88g distilled acrylic acid and 14.5g methanol were placed in a 50ml round bottom flask and flushed with nitrogen. 0.2625g benzoyl peroxide was added and after heating at 60-70 degrees centigrade for 48 hours the conversion was 70%. The polymer swelled in methanol but was insoluble in water.
Similar preparations were achieved with different ratios of the monomers acrolein: acrylic acid namely, 30:70 (Example 9),' 10:90 (Example 10), 2.5:97.5 (Example 11). The . products from Examples 10 and 11 were soluble in water and retained by dialysis tubing of exclusion 2,000mwt. Example 12
In a similar preparation to the above, 42% conversion was achieved of a polymer which swelled in methanol or water, from 1.8g acrolein, 3.3g vinyl pyrrolidone and 0.071g azobisisobutyronitrile.
Example 13
30mg benzoyl peroxide was added to a solution of
10 1.02g polyethyleneglycol acrylate and 0.5ml acrolein in 5ml methanol. The mixture was stirred and heated to reflux for 48 hours and gave 90% conversion; the residual oil (1.2g) was chromatographed on Sephadex LH-20 (18g) in methanol. The structure of the resulting polymer was confirmed by NMR , c analysis.
Examples 14-19
Whatman 5.5cm .filter paper was immersed in the following solutions and irradiated by a cobalt source for 4 0 hours: Example Acetyl diethyl acetal Acrylic . Acid Methanol
14 2.0ml 0ml 18ml
15 1.6ml 0.4ml 18ml
16 1.2ml 0.8ml 18ml 5 17 1.0ml 1.0ml 18ml
18 0.4ml 1.6ml 18ml
19 2.0ml* 0ml 18ml * Acrolein diacetoxy acetal r
Filter papers were dried in an oven at 70 degrees 0 centigrade for 30 minutes and weighing indicated the grafting of polymer 0.8%-12.6%. (These yields were recorded after washing with methanol).
Example 20 5 A small cellulosic paper disk which is normally used for filtration i.e. a filter paper, about 2 cms. in diameter was immersed in a 10% solution of acrolein in water (10 ml), contained in a tube. The tube and its contents were flushed with nitrogen, sealed, and then gamma-radiated for one hour from a cobalt source (approximately 0.7 Mrad/hour). The disk was then removed and washed with water.
The following standard strains were used for testing: a) Staphylococcus aureus (Oxford) b) Pseudomonas ATCC c) Candida ATCC
Dilutions were prepared in normal saline. lOul of each bacterial solution was applied to 1 square centimetre of test filter paper. Filter papers were maintained in a moist atmosphere at room temperature for 2 hours. Filter papers were then transferred to 5ml heart brain infusion and shaken at 37 degrees centigrade for 30 minutes. lOul was removed for sterility testing and the flasks incubated at 37 degrees centigrade for 18 hours. The flasks were inspected for growth and the growth was checked on blood agar.
Staphylococcus Pseudomonas Candida
Concentration Control Test Control Test Control Test cfu/ l (10 log) 10 + +
9 + +
8 + +
7 + +
6 + +
5 + +
4 + +
3 + + = growth - - kill Example 21
Whatman No. 4 filterpaper was impregnated with a solution of polyacrolein in methanol which had been polymerised by means of gamma-radiation) and dried in an oven at 70 degrees centigrade for 1 hour. The amount of impregnated polymeric antimicrobial was 9%. The impregnated filter paper was tested for antimicrobial activity and the results were recorded by comparing with a control filter¬ paper.
The following standard strains were used for testing: a) Staphylococcus aureus (Oxford) b) Pseudomonas ATCC c) Candida ATCC Dilutions were prepared in normal saline. lOul of each bacterial dilution was applied to 1 square centimetre of test filter paper. The filter papers were maintained in a moist atmosphere at room temperature for 2 hours. Then the filter papers were transferred to 5ml heart brain infusion and shaken at 37 degrees centigrade for 30 minutes. 1.0ul was removed for sterility testing and the flasks incubated at 37 degrees centigrade for 18 hours. The flasks were inspected for growth and the growth was checked on blood agar.
Staphylococcus Pseudomonas Candida Concentration Control Test Control Test Control Test cfu/ml (10 log)
10 + - r +
9 + - + - + C
8 + - + C
7 + - +
6 + - +
5 + - +
4 + - - - + -
3 + _
+ = growth
- = kill
C = contaminated Example 22
Whatman No. 4 filterpaper was impregnated with a solution of polyacrolein. In methanol, which has been prepared by polymerising 19.3g distilled acrolein in 58 g methanol in the presence of 1.05g benzoylperoxide in a nitrogen atmosphere for 3 days at 70 degrees centigrade. The amount of impregnated polymeric antimicrobial was 8%. The impregnated filterpaper was tested for antimicrobial activity and the results were recorded by comparing with a control filterpaper.
The following standard strains were used for testing: a) Staphylococcus aureus (oxford) b) Pseudomonas ATCC c) Candida ATCC
Dilutions were prepared in normal saline.
10ml of each bacterial dilution was applied to 1 square centimetre test filter paper. The filter papers were maintained in a moist atmosphere at room temperature for 2 hours. Then, the filter papers were transferred to 5ml heart brain infusion and shaken at 37 degrees centigrade for 30 minutes. The flasks were incubated at 37 degrees centigrade for 18 hours, inspected for growth and the growth was checked on blood agar.
Staphylococcus Pseudomonas Candida
Concentration Cont L Test Control Test Control Test cfu/ml (10 log)
10 + +
9 + +
8 + +
7 +- +
6 C
+ = growth
- = kill
C = contaminated Example 23
Twice, in separate experiments, cotton wool was impregnated with a solution of polyacrolein in methanol which had been prepared by polymerizing 19.3g distilled acrolein in 58g methanol in the presence of 1.05 g benzoylperoxide in a nitrogen atmosphere for 3 days at 70 degrees centigrade. The amount of impregnated, polymeric antimicrobial was 5% and 3.5% respectively. The impregnated cottonwools were tested for antimicrobial activity and the results were recorded by comparing with control cottonwool.
The following standard strains were used for testing: a) Staphylococcus Aureus (Oxford) b) Pseudomonas ATCC
Dilutions were prepared in normal saline.
5mg amounts of cottonwool were weighed and placed in sterile bijoux bottles. The cottonwool was saturated with 30ul of 5 different bacterial dilutions. After 2 hours at room temperature, the cottonwool was transferred to 5ml of heart brain infusion and incubated for 18 hours at 37 degrees centigrade. Cultures were inspected for growth and growth was checked by plating on blood agar.
Staphylococcus Pseudomonas Concentration Control 3.5% 5% Control 3.5% 5% cfu/ml (10 log)
5 + - - + - -
4 + - - + - -
3 + - 7 + - -
2 + - - + - -
1 + _
+ = growth - = kill
It will be evident that these laboratory scale examples may be extended to industrial scale processes, for example, in which the substrate cellulose, prior to incorporation in, for example, tampons, diapers or medical cellulosic products is treated with acrolein vapour or acrolein solution and is then gamma-irradiated. Further, the process may be extended to the continuous (as well as batch) industrial processes in which cotton, cellulosic fibre or other fibres^are treated with acrolein vapours or solution prior to weaving or making into a non-woven fabric. Still further, the laboratory scale example may be extended to treating sheets, fabrics or cloths prior to making into clothes, drapes and other similar finished products. Still further, the example may be extended to treating the starting-materials or their final products such as ceramics, masonry, bricks, concrete, glass or plastics materials either prior to or after making these into their final fabricated forms.
Example 24
Many other substrates were treated with solutions containing active polymers, for example, gauze from bandages, non-woven fabric from sanitary napkins, cottonwool from tampons - and always before microbiological testing, a control was used on the substrate which had been treated with the pure.* solvent (methanol). Substrates which had been treated with the methanolic solutions of the polymers were always dried at 80 degrees centigrade/1.5 hours before antimicrobial testing - and as well, extracts were made with both methanol and physiological saline to test for the presence of monomer; this was found by HPLC and GC to be less than lOppm at which the acrolein was found to be microbiologically inactive during our tests:
Cotton (3.876g) with a 3% content of polyacrolein was agitated in saline (75ml) for 24 hours.
The saline extract was analysed by GLC (10% carbowax 20M and on FID detector) which showed that the cotton contained less than 20ppm (the limit of detection).
The saline extract (50ml) was added to a solution of 2,4-dinitrophenylhydrazine (O.lOOg) in 2N hydrochloric acid (25ml). The resultant solution was extracted with chloroform (3 x 5ml). The combined organic fractions were then washed with 2N hydrochloric acid (2 x 5ml), water (2 x 5ml) and dried (sodium sulphate). The chloroform was evaporated to dryness and the residue dissolved in aceto- nitrile (1ml). Analysis of the acetonitrile by HP C (C18 reverse phase, 70% aqueous mmethanol, UV detector at 245nm) showed that the cotton contained 2.4ppm of acrolein.
Typically, substrates which were found to be micro- biologically active, retained their activities after more than 6 months' standing at room temperature.
The following are typical and additional test- results, executed similarly to examples 20-23: Example No. Active Agent
Staphyloccocus Pseudomonas Candida
1* + + +
2** + + +
3 + NT NT
4 + NT NT
5 + NT NT
6 + NT NT
7 + + +
8 , + + +
9 + + + 10** + + + 11** + + +
12 + NT NT
13 NT + NT
14 + NT NT
15 + NT NT
16 + NT NT
17 + NT NT
18 + NT NT
19 + NT NT NT = not tested + = positive/active
* (a) Tests were also carried out in phosphate buffers, adjusted with sodium hydroxide to give pH's of 5, _ _
6, 7, 8 and 9, respectively; results against
Staphlococcus (Oxford) at levels 103 - 108 showed no differences in activities at the respective pH's.
Activities were also retained at the level of 25 ul heparinized blood or urine, respectively (both human) .
(b) In another experiment, a methanolic solution was applied to spore strips of Bacillus subtilis var niger and left in contact at room temperature for 2 hours before transferring to heart brain infusion for 18 hours/37 degrees centigrade. The cultures were inspected for growth and plated to blood agar - the solution of polymer being active against the spores, whilst the methanol—solvent was inactive under these conditions.
(c) In separate experiments, O.lg of cotton wool which had been coated with the polymer, was aseptically weighed into separate sterile bijoux bottles. The cotton wool was then incubated with 0.5ml of dilutions of cultures of Erwinia carotovora (Important in soft rot of potatoes or cabbages), S.Aureus (important regarding bovine mastilis) and Salmonella dublin (important regarding bovine calf mortality) , respectively. These were left at room temperature for 2 hours and then the cotton wool was transferred to TSB, an enriched nutrient broth and incubated at 32 degr-ees centigrade, 37 degrees centigrade and 37 degrees centigrade, respectively. The coating on the respective cotton wools killed the 3 organisms respectively, in the range 10 -10 /ml of pathogens.
(d) In separate and similar experiments (except the media used was malt extract broth, Sabouraud dextrose agar, 0.1% peptone water as diluent), kills were achieved in the range 102-105/ml of Aureobasidium pullurans (associated with black-slime on bathroom tiles and groutings) and pycnoporus coccineus (associated with rotting in timbers) .
(e) In 3 separate experiments, tests were also conducted for anti-viral activities and found active in each case, using the following method for
Herpes Simplex, Enterovirus, Echo 11 and Influenza
PR8, respectively: a 104/ml suspension of the viral particles was applied to cottonwool treated with the antimocrobial polymer, followed by centrifugation. 0.1 ml aliquots of the centrifugate were introduced into cultures of human embryonic fibroblasts or HeLa cells and the cytopathic effect noted.
** Also active in a preservative test conducted over 14 days at pH 7.5 in glycerol-triethanolamine buffer, against
Pseudomonas ATCC dilutions prepared in normal saline.
"Staphylococcus", Pseudomonas" and "Candida" referred to herein are more specificically identified as: • Staphlycoccus aureus NCTC 6571
Pseudomonas aeruginosa ATCC 27853 Candida albicans PMH 82/312

Claims

_ .THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS:
1. A polymeric biocidal or biostatic compound having the polymeric repeating unit
- CH2 - CH - CH2 - CH - CHO CHO or this repeating unit in hydrated, hemi-acetal or acetal forms described in Figures 1 and 2.
2. A polymeric biostatic or biocidal composition, being a solution, gel, emulsion or suspension of matter comprising a compound as claimed in Claim 1.
3. A composition according to Claim 2 which is used as a preservative for foods, cosmetics, toiletries, pharmaceuticals, oils or lubricants; as a sterilent, antimicrobial or sanitizer in agricultural or veterinary applications, or as a solution, emulsion, suspension or gel for specific-use against AIDS microorganism(s) .
4. A polymeric biocidal or biostatic composition of matter comprising a compound as claimed in claim 1 bound to a substrate or substrate material.
5. A composition of matter as claimed in claim 4 in which the substrate is selected from the group of materials consisting of : cellulose, modified cellulose, regenerated cellulose, rayon, polymers of plastic materials such as vinyl polymers, acrylic polymers and polyesters, rubbers and various materials such as ceramics, glass, silica, concrete, masonry, minerals and earths.
6. A composition of matter as claimed in claim 5 in the form of airconditioner filters, air-line wipes, aprons, bags for laundry, bandages or adhesive bandages, bathroom tiles or grout, bricks, car or other carpets, catheters and related hospital instruments made from plastic or glass, clothing including underwear, cloth wraps for food, concrete, cottonballs or cotton tips (buds), diapers, disposable towels, drapes (domestic, commercial or industrial hospital), disposable cardboard or plastic food boxes, face masks (hospital or industrial) bed covers, inners of shoes, ironing board covers, jumpers or cardigans, nursing pads, paint for ships' hulls or underwater pylons, paper plates and cups, water reservoirs or swimming pool or water-treatment chemicals, rubbish bins made from cardboard or plastic, sanitary napkins or feminine hygiene tampons, sheeting for babies' or incontinent persons' beds, shelving paper, shower curtains, socks, sterile gloves, sterile overalls, teatowels, telephones - diaphragms for mouth pieces, tents, tissues, handkerchiefs, toilet paper, toothbrush, nylons, towels, wall paper, window awnings or other like structures made from canvas plastic etc., wipes, mops, sponges, wood or wood-impregnants.
7. A process for producing a polymeric biocidal or biostatic compound having the polymeric repeating unit
- CH2 - CH - CH2 - CH - CHO CHO or this repeating unit in hydrated, hemi-acetal or acetal forms described in Figures 1 and 2 which comprises polymerizing acrolein or a derivative thereof.
8. A process as claimed in .claim 7 in which the process is effected or carried out in the presence of a polymerization inducing agent.
9. A process as claimed in claim 8 wherein the polymerization inducing agent comprises anionic catalyst, gamma radiation, a free radical catalyst, ultra violet radiation or electron beam radiation or a combination thereof.
10. A process for preparing a composition of matter as claimed in any one of claims 2 to 6 which comprises polymerizing acrolein or a derivative thereof in the presence of the substrate or substrate material.
11. A process as claimed in claim 10 in which the process is carried out in the presence of a polymerization inducing agent comprising an ionic catalyst, gamma radiation, a free radical catalyst, ultraviolet radiation or electron beam radiation or a combination thereof.
12. A biocidal or biostatic compound, substrate, substrate material or textile or other article or method of preparation thereof substantially as herein described.
PCT/AU1987/000435 1986-12-23 1987-12-21 Biostatic and biocidal compositions WO1988004671A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
KR1019880701031A KR950008720B1 (en) 1986-12-23 1987-12-21 Biostatic and biocidal compositions
DE3789150T DE3789150T2 (en) 1986-12-23 1987-12-21 BIOCIDES BIOSTATIC COMPOSITIONS.
IN992/CAL/87A IN166555B (en) 1986-12-23 1987-12-22
AT88900672T ATE101860T1 (en) 1986-12-23 1988-07-05 BIOCIDES BIOSTATIC COMPOSITIONS.
NO883639A NO173737C (en) 1986-12-23 1988-08-16 Polymeric composition having biocidal or biostatic properties, its preparation and its use
DK198804697A DK174224B1 (en) 1986-12-23 1988-08-22 Polymer biocide or biostatic compound and process for making same and its use
SG81394A SG81394G (en) 1986-12-23 1994-06-23 Biostatic and biocidal compositions.
HK103394A HK103394A (en) 1986-12-23 1994-09-29 Biostatic and biocidal compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPH9657 1986-12-23
AUPH965786 1986-12-23

Publications (1)

Publication Number Publication Date
WO1988004671A1 true WO1988004671A1 (en) 1988-06-30

Family

ID=3771970

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU1987/000435 WO1988004671A1 (en) 1986-12-23 1987-12-21 Biostatic and biocidal compositions

Country Status (16)

Country Link
US (1) US5290894A (en)
EP (1) EP0339044B1 (en)
JP (1) JP2857756B2 (en)
KR (1) KR950008720B1 (en)
AT (1) ATE101860T1 (en)
CA (1) CA1320128C (en)
DE (1) DE3789150T2 (en)
DK (1) DK174224B1 (en)
HK (1) HK103394A (en)
IN (1) IN166555B (en)
MY (1) MY102278A (en)
NO (1) NO173737C (en)
NZ (1) NZ222979A (en)
PH (1) PH23983A (en)
WO (1) WO1988004671A1 (en)
ZA (1) ZA879640B (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079266A (en) * 1988-01-04 1992-01-07 Betz Laboratories, Inc. Method of generating acrolein
US5261421A (en) * 1988-04-23 1993-11-16 Smith & Nephew Plc Gloves, their manufacture and use
DE19500386A1 (en) * 1995-01-09 1996-07-11 Degussa Process for the preparation of pendant aldehyde group-bearing copolymers
EP0792895A1 (en) * 1996-02-22 1997-09-03 Degussa Aktiengesellschaft Acrolein releasing copolymers
DE19653303A1 (en) * 1996-02-22 1997-09-25 Degussa Acrolein releasing copolymers
EP0828498A1 (en) * 1995-05-30 1998-03-18 Chemeq Pty Ltd. Chemotherapeutic compositions
EP0849297A1 (en) * 1996-12-20 1998-06-24 Degussa Ag Acrolein releasing emulsion homopolymer
EP0945405A2 (en) 1998-03-23 1999-09-29 Degussa-Hüls Aktiengesellschaft Solutions of peracids for stabilizing hardness, method of preparation, and their use
WO2000003723A1 (en) * 1998-07-17 2000-01-27 Chemeq Limited Polymeric compounds and methods of formulating same
US6060571A (en) * 1996-02-22 2000-05-09 Degussa Aktiengesellschaft Acrolein-releasing copolymers
WO2003061672A1 (en) * 2002-01-18 2003-07-31 Chemeq Ltd Method of treatment of gastrointestinal disease and polymeric composition for use therein
EP1689795A1 (en) * 2003-11-06 2006-08-16 Chemeq Ltd. Method of manufacture of polyacrolein
AU2003201209B2 (en) * 2002-01-18 2008-08-07 Chemeq Ltd Method of treatment of gastrointestinal disease and polymeric composition for use therein
WO2011098706A1 (en) 2010-02-15 2011-08-18 Arkema France Method for obtaining acrolein polymers, polymers, and uses thereof
US11045491B2 (en) 2016-02-19 2021-06-29 Recce Pharmaceuticals Ltd Anti-virus agent and method for treatment of viral infection

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543456A (en) * 1993-09-27 1996-08-06 Nippon Shokubai Co., Ltd. Process for preparing an aqueous resin dispersion and an aqueous resin dispersion obtained by the process
EP0645405A1 (en) 1993-09-27 1995-03-29 Nippon Shokubai Co., Ltd. Process for preparing an aqueous resin dispersion and an aqueous resin dispersion obtained by the process
DE4404404A1 (en) * 1994-02-11 1995-08-17 Degussa Acrolein polymer
US6060235A (en) * 1997-09-19 2000-05-09 Geltex Pharmaceuticals, Inc. Antiviral polymers comprising acid functional groups and hydrophobic groups
US6146688A (en) * 1997-12-23 2000-11-14 Morgan; Harry C. Method of creating a biostatic agent using interpenetrating network polymers
US6195805B1 (en) 1998-02-27 2001-03-06 Allegiance Corporation Powder free neoprene surgical gloves
GB2344104B (en) * 1998-11-27 2004-04-07 Hyundai Electronics Ind Photoresist composition comprising a cross-linker
US20050065284A1 (en) * 1999-08-06 2005-03-24 Venkataram Krishnan Novel latex compositions for deposition on various substrates
KR100549574B1 (en) * 1999-12-30 2006-02-08 주식회사 하이닉스반도체 Organic anti-reflective coating polymers and preparation thereof
US7629002B2 (en) * 2000-02-16 2009-12-08 Chemeq Ltd. Antimicrobial polymeric compositions and method of treatment using them
US6803356B1 (en) * 2000-02-16 2004-10-12 Chemeq Ltd. Antimicrobial polymeric compositions
AUPQ656200A0 (en) * 2000-03-29 2000-04-20 Novapharm Research (Australia) Pty Ltd Chemical upgrading of filters
AUPQ656300A0 (en) * 2000-03-29 2000-04-20 Novapharm Research (Australia) Pty Ltd Biostatic filter
AUPR040600A0 (en) * 2000-09-27 2000-10-19 Chemeq Ltd Polymeric formulation
WO2003002163A1 (en) * 2001-06-29 2003-01-09 The Procter & Gamble Company Absorbent article
AU2003289459A1 (en) * 2002-12-20 2004-07-14 Globe, Inc. Floor mat and small animal rearing cage
US7491753B2 (en) 2003-07-03 2009-02-17 Mallard Creek Polymers, Inc. Antimicrobial and antistatic polymers and methods of using such polymers on various substrates
US7781498B2 (en) * 2003-07-03 2010-08-24 Mallard Creek Polymers, Inc. Cationic latex as a carrier for bioactive ingredients and methods for making and using the same
US7981946B2 (en) * 2003-07-03 2011-07-19 Mallard Creek Polymers, Inc. Antimicrobial and antistatic polymers and methods of using such polymers on various substrates
WO2006102367A1 (en) * 2005-03-22 2006-09-28 Biosafe Inc. Method of creating a solvent-free polymeric silicon-containing quaternary ammonium antimicrobial agent having superior sustained antimicrobial properties
JP4797419B2 (en) * 2005-03-30 2011-10-19 東洋製罐株式会社 Method for producing aldehyde group-containing copolymer
JP4779405B2 (en) * 2005-03-30 2011-09-28 東洋製罐株式会社 Gas barrier resin, gas barrier material using the same, coating liquid, packaging material, and method for producing gas barrier material
US20070048249A1 (en) 2005-08-24 2007-03-01 Purdue Research Foundation Hydrophilized bactericidal polymers
JP5378217B2 (en) 2006-08-24 2013-12-25 マラード クリーク ポリマーズ,インコーポレーテッド Anionic latex as carrier for biologically active ingredients and methods for making and using the same
US20080207774A1 (en) * 2006-08-24 2008-08-28 Venkataram Krishnan Anionic latex as a carrier for active ingredients and methods for making and using the same
CN101516382A (en) * 2006-08-24 2009-08-26 马拉德克里科聚合物公司 Cationic latex as a carrier for bioactive ingredients and methods for making and using the same
US20080233062A1 (en) * 2006-08-24 2008-09-25 Venkataram Krishnan Cationic latex as a carrier for active ingredients and methods for making and using the same
TW200901890A (en) * 2007-04-03 2009-01-16 Sure Internat Ventures B V New compostions and methods for cell killing
US20100266653A1 (en) * 2007-07-19 2010-10-21 Chemeq Ltd Biocidal polyacrolein composition
CN101977945B (en) * 2007-11-07 2015-11-25 瑞克有限公司 Anti-microbial polymer and composition thereof
US9587349B2 (en) * 2008-04-30 2017-03-07 Xyleco, Inc. Textiles and methods and systems for producing textiles
US8163192B2 (en) * 2009-06-26 2012-04-24 Vincelli Sr Fred Hydroseed substrate and method of making such
US8163194B2 (en) 2009-06-26 2012-04-24 Vincelli Sr Fred Hydroseed substrate and method of making such
EP2744938B1 (en) 2011-09-13 2016-09-07 Koninklijke Philips N.V. Ironing board cover
EP2692365A1 (en) * 2012-08-03 2014-02-05 MaRVis Medical GmbH Implantable or insertable MRI-detectable medical device having a coating comprising paramagnetic ions and a process for preparing it
US20180340046A1 (en) 2017-05-27 2018-11-29 Poly Group LLC Dispersible antimicrobial complex and coatings therefrom
EP3638740A1 (en) 2017-06-16 2020-04-22 Poly Group LLC Polymeric antimicrobial surfactant
CN112300307A (en) * 2019-07-25 2021-02-02 长沙理工大学 Preparation method of free radical initiated polyacrylamide and application of free radical initiated polyacrylamide in field of antibacterial materials

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1312166A (en) * 1960-12-22 1962-12-14 Shell Int Research Process for the preparation of derivatives of polymers or copolymers of ethylenically unsaturated alpha, beta aldehydes
GB946663A (en) * 1959-05-05 1964-01-15 Gen Tire & Rubber Co Graft copolymers of alkyl ª -substituted acroleins and reaction products thereof
US3635898A (en) * 1969-07-03 1972-01-18 Gaf Corp Process for polymerization of acrolein
US4016127A (en) * 1971-07-06 1977-04-05 Rohm And Haas Company Emulsion copolymers of acrolein and their use in treating leather

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA748859A (en) * 1966-12-20 W. Racusen David Soil fumigant
CA745398A (en) * 1966-11-01 Armand Charette Joint de briques, blocs de ciment et analogues
CA723213A (en) * 1965-12-07 Elliott E. Ryder, Jr. Process for polymerizing unsaturated aldehydes and resulting products
CA748848A (en) * 1966-12-20 M. Henson Paul Paper roll finishing apparatus
US2657192A (en) * 1951-01-25 1953-10-27 Du Pont Polymerization of acrolein
NL99604C (en) * 1955-03-23
US3079357A (en) * 1959-12-14 1963-02-26 Shell Oil Co Process for preparing high molecular weight polymers from acrolein and resulting products
US3149000A (en) * 1961-12-15 1964-09-15 Simoniz Co Hydrophilic polyurethane sponge
CH465513A (en) * 1963-02-16 1968-11-15 Degussa Process for compacting and consolidating in order to increase the sealing and water-binding capacity of soils, soil formations, structures, building elements and building materials
US3843684A (en) * 1972-02-16 1974-10-22 Gaf Corp Alpha,omega-pyrrolidonyl polyacrolein
DE2404742A1 (en) * 1974-02-01 1975-08-07 Hoechst Ag PROCESS FOR THE MANUFACTURING OF COPOLYMERS UNSATURATED ALDEHYDE
DE3205487C1 (en) * 1982-02-16 1983-10-13 Degussa Ag, 6000 Frankfurt Use of polycondensation products from acrolein and formaldehyde as biocides

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB946663A (en) * 1959-05-05 1964-01-15 Gen Tire & Rubber Co Graft copolymers of alkyl ª -substituted acroleins and reaction products thereof
FR1312166A (en) * 1960-12-22 1962-12-14 Shell Int Research Process for the preparation of derivatives of polymers or copolymers of ethylenically unsaturated alpha, beta aldehydes
US3635898A (en) * 1969-07-03 1972-01-18 Gaf Corp Process for polymerization of acrolein
US4016127A (en) * 1971-07-06 1977-04-05 Rohm And Haas Company Emulsion copolymers of acrolein and their use in treating leather

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
H.F. MARK et al, 'Encyclopedia of Polymer Science and Technology', Volume 2, published 1965, by Interscience Publishers (A Division of JOHN WILEY & Sons) (New York, London, Sydney) see pages 493 to 494 *
KIRK-OTHMER, 'Encyclopedia of Chemical Technology', (3rd Edition), Volume 13, published 1981 by WILEY-Interscience (New York) see pages 247 to 248 *

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079266A (en) * 1988-01-04 1992-01-07 Betz Laboratories, Inc. Method of generating acrolein
US5261421A (en) * 1988-04-23 1993-11-16 Smith & Nephew Plc Gloves, their manufacture and use
DE19500386A1 (en) * 1995-01-09 1996-07-11 Degussa Process for the preparation of pendant aldehyde group-bearing copolymers
EP0828498A4 (en) * 1995-05-30 2000-04-05 Chemeq Ltd Chemotherapeutic compositions
EP1393735A2 (en) * 1995-05-30 2004-03-03 CHEMEQ Limited Chemotherapeutic compositions
EP0828498A1 (en) * 1995-05-30 1998-03-18 Chemeq Pty Ltd. Chemotherapeutic compositions
US7438899B2 (en) * 1995-05-30 2008-10-21 Chemeq Ltd. Chemotherapeutic compositions
EP1393735A3 (en) * 1995-05-30 2004-03-10 CHEMEQ Limited Chemotherapeutic compositions
EP0792895A1 (en) * 1996-02-22 1997-09-03 Degussa Aktiengesellschaft Acrolein releasing copolymers
US6060571A (en) * 1996-02-22 2000-05-09 Degussa Aktiengesellschaft Acrolein-releasing copolymers
DE19653303A1 (en) * 1996-02-22 1997-09-25 Degussa Acrolein releasing copolymers
EP0849297A1 (en) * 1996-12-20 1998-06-24 Degussa Ag Acrolein releasing emulsion homopolymer
US5917094A (en) * 1996-12-20 1999-06-29 Degussa-Huls Aktiengesellschaft Acrolein-releasing emulsion homopolymers
EP0945405A2 (en) 1998-03-23 1999-09-29 Degussa-Hüls Aktiengesellschaft Solutions of peracids for stabilizing hardness, method of preparation, and their use
US6410040B1 (en) 1998-07-17 2002-06-25 Chemeq Limited Polymeric compounds and methods of formulating same
WO2000003723A1 (en) * 1998-07-17 2000-01-27 Chemeq Limited Polymeric compounds and methods of formulating same
WO2003061672A1 (en) * 2002-01-18 2003-07-31 Chemeq Ltd Method of treatment of gastrointestinal disease and polymeric composition for use therein
AU2003201209B2 (en) * 2002-01-18 2008-08-07 Chemeq Ltd Method of treatment of gastrointestinal disease and polymeric composition for use therein
EA015165B1 (en) * 2002-01-18 2011-06-30 КЕМЕК эЛТиДи Method for preparing a medicament of poly(2-propenal, 2-propenoic acid for the treatment or prophylaxis of gastrointestinal disease and antimicrobal composition for use therein
EP1689795A1 (en) * 2003-11-06 2006-08-16 Chemeq Ltd. Method of manufacture of polyacrolein
EP1689795A4 (en) * 2003-11-06 2008-03-05 Chemeq Ltd Method of manufacture of polyacrolein
WO2011098706A1 (en) 2010-02-15 2011-08-18 Arkema France Method for obtaining acrolein polymers, polymers, and uses thereof
US11045491B2 (en) 2016-02-19 2021-06-29 Recce Pharmaceuticals Ltd Anti-virus agent and method for treatment of viral infection

Also Published As

Publication number Publication date
NO173737B (en) 1993-10-18
ATE101860T1 (en) 1994-03-15
AU1086488A (en) 1988-07-15
US5290894A (en) 1994-03-01
EP0339044A1 (en) 1989-11-02
AU616166B2 (en) 1991-10-24
JP2857756B2 (en) 1999-02-17
HK103394A (en) 1994-10-07
NO883639D0 (en) 1988-08-16
NZ222979A (en) 1990-09-26
DE3789150T2 (en) 1994-07-28
IN166555B (en) 1990-06-09
ZA879640B (en) 1989-09-27
CA1320128C (en) 1993-07-13
DK469788A (en) 1988-10-24
EP0339044A4 (en) 1990-05-14
DK469788D0 (en) 1988-08-22
NO173737C (en) 1994-01-26
PH23983A (en) 1990-02-09
DE3789150D1 (en) 1994-03-31
DK174224B1 (en) 2002-09-30
JPH02501750A (en) 1990-06-14
MY102278A (en) 1992-05-15
EP0339044B1 (en) 1994-02-23
KR890700617A (en) 1989-04-26
NO883639L (en) 1988-10-12
KR950008720B1 (en) 1995-08-04

Similar Documents

Publication Publication Date Title
US5290894A (en) Biostatic and biocidal compositions
US5830526A (en) Light-activated antimicrobial and antiviral materials
CN1291101C (en) Durable and regeneratable microbe killing fabric
Laga et al. Use of nano silver as an antimicrobial agent for cotton
EP0893165A2 (en) Bioactive coating of surfaces using macroinitiators
US8486428B2 (en) Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric materials and articles
CN102131836A (en) Antimicrobial polymers and coatings
US5843375A (en) Method for decontamination of a liquid of gaseous environment
WO2013020096A2 (en) Antimicrobial materials and methods
CN102083310A (en) Antimicrobial agent, method of preparing an antimicrobial agent and articles comprising the same
WO2001072859A1 (en) Microbicidal coatings containing acrylo-substituted alkylsulphonic acid polymers
JP3529059B2 (en) Antibacterial deodorant
AU616166C (en) Biostatic and biocidal compositions
EP0852238B1 (en) Polymers with bacteriophobe and optionally cell proliferation inhibitant properties
JP2009035836A (en) Antimicrobial nonwoven fabric
DE69818074T2 (en) ANTIMICROBIAL AGENT
CN112878045A (en) Air-permeable hydrophilic antibacterial antiviral medical cloth containing iodine compound
DE19700081A1 (en) Anti-bacterial covalently bonded coating
JP3711412B2 (en) Antibacterial agent, antibacterial fiber and method for producing the same
CN87108390A (en) Suppress biological and biocidal composition
JPH10231373A (en) Method for bioactive coating of base body surface and application of coated base body
WO2002099181A1 (en) Antimicrobial nonwoven fabrics
WO2022193030A1 (en) Antiviral and antimicrobial coatings and methods thereof
JP3906346B2 (en) Antibacterial fiber and production method thereof
DE19720370A1 (en) Bioactive coating of surfaces

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR DK FI HU JP KR LK NO RO SU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1988900672

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1988900672

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1988900672

Country of ref document: EP